Heidelberg Pharma AG buy melinda
Start price
15.10.18
/
50%
€2.08
Target price
18.10.18
€2.45
Performance (%)
8.17%
End price
18.10.18
€2.25
Summary
This prediction ended on 18.10.18 with a price of €2.25. With a performance of 8.17%, the BUY prediction by melinda for Heidelberg Pharma AG closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Heidelberg Pharma AG | 0.000% | 0.000% | -24.041% | -51.471% |
| iShares Core DAX® | 1.851% | 5.158% | 17.711% | 19.954% |
| iShares Nasdaq 100 | 1.573% | 2.589% | 39.053% | 56.636% |
| iShares Nikkei 225® | -0.412% | -2.857% | 13.501% | 7.721% |
| iShares S&P 500 | 1.128% | 2.485% | 29.871% | 47.507% |
According to melinda what are the pros and cons of Heidelberg Pharma AG for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Heidelberg Pharma AG diskutieren
SecteurRecherche biotechnologique et médicale Agenda 17/10 Présentation
Heidelberg Pharma AG engages in the development of diagnostic and therapeutic products for the detection and targeted treatment of various types of cancer.
It operates through the following segments: Customer Specific Research (Cx), Diagnostics (Dx), andTherapeutics (Rx).
The Customer Specific Research segment includes preclinical and Antibody Drug Conjugate technology services.
The Diagnostics segment handles the imaging diagnostic candidate REDECTANE.
The Therapeutics segment comprises of the following programmes: MESUPRON, WX-554, WX-037 as well as all preclinical and research activities of Heidelberg Pharma AG. The company was founded by Olaf G. Wilhelm, Manfred Schmitt, Viktor Magdolen, Heinrich Graeff, Bernd Gänsbacher, Horst Kessler, Peter Nawroth, and Thomas Luther in September 1997 and is headquartered in Munich, Germany.
Nombre d'employés : 58 personnes.
Stopped prediction by melinda for Heidelberg Pharma AG
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€2.68
16.03.20
16.03.20
€3.00
04.11.21
04.11.21
120.15%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€2.98
15.11.17
15.11.17
€4.00
16.01.18
16.01.18
20.81%
16.01.18
16.01.18
Could be worthwhile Investment >10% per year
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€2.98
15.11.17
15.11.17
€4.00
16.01.18
16.01.18
20.81%
16.01.18
16.01.18
Could be worthwhile Investment >10% per year